“Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]

Detalles Bibliográficos
Autores principales: Gopichand, Pallam, Agarwal, Girija, Natarajan, Mailan, Mandal, Jharna, Deepanjali, Surendran, Parameswaran, Sreejith, Dorairajan, LN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Response to Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781579/
https://www.ncbi.nlm.nih.gov/pubmed/31632099
http://dx.doi.org/10.2147/IDR.S231341
_version_ 1783457398960160768
author Gopichand, Pallam
Agarwal, Girija
Natarajan, Mailan
Mandal, Jharna
Deepanjali, Surendran
Parameswaran, Sreejith
Dorairajan, LN
author_facet Gopichand, Pallam
Agarwal, Girija
Natarajan, Mailan
Mandal, Jharna
Deepanjali, Surendran
Parameswaran, Sreejith
Dorairajan, LN
author_sort Gopichand, Pallam
collection PubMed
description
format Online
Article
Text
id pubmed-6781579
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67815792019-10-18 “Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter] Gopichand, Pallam Agarwal, Girija Natarajan, Mailan Mandal, Jharna Deepanjali, Surendran Parameswaran, Sreejith Dorairajan, LN Infect Drug Resist Response to Letter Dove 2019-10-03 /pmc/articles/PMC6781579/ /pubmed/31632099 http://dx.doi.org/10.2147/IDR.S231341 Text en © 2019 Gopichand et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Response to Letter
Gopichand, Pallam
Agarwal, Girija
Natarajan, Mailan
Mandal, Jharna
Deepanjali, Surendran
Parameswaran, Sreejith
Dorairajan, LN
“Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]
title “Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]
title_full “Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]
title_fullStr “Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]
title_full_unstemmed “Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]
title_short “Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]
title_sort “is fosfomycin as effective as claimed on mdr gram-negative bacteria causing uti?” [response to letter]
topic Response to Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781579/
https://www.ncbi.nlm.nih.gov/pubmed/31632099
http://dx.doi.org/10.2147/IDR.S231341
work_keys_str_mv AT gopichandpallam isfosfomycinaseffectiveasclaimedonmdrgramnegativebacteriacausingutiresponsetoletter
AT agarwalgirija isfosfomycinaseffectiveasclaimedonmdrgramnegativebacteriacausingutiresponsetoletter
AT natarajanmailan isfosfomycinaseffectiveasclaimedonmdrgramnegativebacteriacausingutiresponsetoletter
AT mandaljharna isfosfomycinaseffectiveasclaimedonmdrgramnegativebacteriacausingutiresponsetoletter
AT deepanjalisurendran isfosfomycinaseffectiveasclaimedonmdrgramnegativebacteriacausingutiresponsetoletter
AT parameswaransreejith isfosfomycinaseffectiveasclaimedonmdrgramnegativebacteriacausingutiresponsetoletter
AT dorairajanln isfosfomycinaseffectiveasclaimedonmdrgramnegativebacteriacausingutiresponsetoletter

Ejemplares similares